Both in Diagnostics
Q/C Technologies vs Myriad Genetics
Over the past year QCLS returned −87.5% and MYGN returned −28.5%; their daily moves had a correlation of 0.01.
QCLS −87.5% MYGN −28.5%Growth of $1, one year, split-adjusted
| Metric | QCLS | MYGN |
|---|---|---|
| Price | $0.4200 | $5.85 |
| Market cap | $3.4M | $559.6M |
| Today | −3.45% | −7.87% |
| 1 month | −43.9% | +28.9% |
| 6 months | −88.9% | +18.4% |
| Year to date | −89.5% | −4.9% |
| 1 year | −87.6% | −26.4% |
| Revenue growth (YoY) | — | −10.5% |
| Gross margin | — | 66.6% |
| Net margin | — | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.7× |
| Net cash | $11.0M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 297.4% | 85.0% |
| Short % of float | 12.2% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).